Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 192

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis

Ågesen, Trude H, Sveen, Anita, Merok, Marianne A, Lind, Guro E, Nesbakken, Arild, Skotheim, Rolf I, Lothe, Ragnhild A · 2012 · Gut

Abstract

Background and aims: Several clinical factors have an impact on prognosis in stage II colorectal cancer (CRC), but as yet they are inadequate for risk assessment. The present study aimed to develop a gene expression classifier for improved risk stratification of patients with stage II CRC. Methods: 315 CRC samples were included in the study. Gene expression measurements from 207 CRC samples (stage I–IV) from two independent Norwegian clinical series were obtained using Affymetrix exon-level microarrays. Differentially expressed genes between stage I and stage IV samples from the test series were identified and used as input for L1 (lasso) penalised Cox proportional hazards analyses of patients with stage II CRC from the same series. A second validation was performed in 108 stage II CRC samples from other populations (USA and Australia). Results: An optimal 13-gene expression classifier ( PIGR , CXCL13 , MMP3 , TUBA1B , SESN1 , AZGP1 , KLK6 , EPHA7 , SEMA3A , DSC3 , CXCL10 , ENPP3 , BNIP3 ) for prediction of relapse among patients with stage II CRC was developed using a consecutive Norwegian test series from patients treated according to current standard protocols (n=44, p<0.001, HR=18.2), and its predictive value was successfully validated for patients with stage II CRC in a second Norwegian CRC series collected two decades previously (n=52, p=0.02, HR=3.6). Further validation of the classifier was obtained in a recent external dataset of patients with stage II CRC from other populations (n=108, p=0.001, HR=6.5). Multivariate Cox regression analyses, including all three sample series and various clinicopathological variables, confirmed the independent prognostic value of the classifier (p≤0.004). The classifier was shown to be specific to stage II CRC and does not provide prognostic stratification of patients with stage III CRC. Conclusion: This study presents the development and validation of a 13-gene expression classifier, ColoGuideEx, for prognosis prediction specific to patients with stage II CRC. The robustness was shown across patient series, populations and different microarray versions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2011-301179

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 192

Metadata

Authors
Ågesen, T. H., Sveen, A., Merok, M. A., Lind, G. E., Nesbakken, A., Skotheim, R. I., & Lothe, R. A.
Venue
Gut
Publisher
BMJ
Published
2012-01-02
Volume
61
Issue
11
Pages
1560-1567
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2109708237
Cited by
192
References
2
FWCI
6.16
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. https://app.cochat.ai/papers/10.1136/gutjnl-2011-301179
The paper
Ågesen, T. H., Sveen, A., Merok, M. A., Lind, G. E., Nesbakken, A., Skotheim, R. I., & Lothe, R. A. (2012). ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut. https://doi.org/10.1136/gutjnl-2011-301179

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.